Posted by alan on August 23, 2002, at 12:23:29
In reply to Re: Fantastic news!!!!!!, posted by moxy1000 on August 23, 2002, at 11:33:18
> My friend is a rep for lilly (prozac manufacturer) and said that he has been talking to physicians for years about the short 1/2 life of paxil and it's subsequent withdrawal like symptoms. He said you wouldn't believe how many doctors said that they NEVER saw withdrawal with paxil and called the information "propaganda."
>
> I thought that was interesting - maybe the docs should listen to their patients a lot more, and maybe their reps at least a little more.
>
>
-------------------------------------------
Then one is really asking for trouble.Are these the same drug reps that deny any "discontinuation syndrome" from any AD because they aren't "habit forming" (code for addicting)? All one has to do is look on this and other health bboards where the majority of discussion revolves around having troubles stopping all of the ssri's. Paxil just got caught doing it - having nothing to do with half-life - but having to do with the emerging complaints about stopping EVERY AD.
It reminds me of those that mistakenly refer to longer half-life bzds as "less addictive" than the shorter half life bzds. Of course this is bogus since there is no chemical rationale to substantiate such a claim.
Tapering off a longer acting psychtropic med may be less difficult for some because the drug leaves the body more slowly. But that doesn't exclude the probability that even though ssri's aren't (yet) classified as controlled substances because of a withdrawl (euphemistically "discontinuation syndrome" or tolerance as "poop-out") that they don't carry with them these inherent characteristics of controlled substances.
The previous marginalizing of benzos to get market share in treating anxiety disorders is going to look pretty rediculous in a couple or so years when all of this eventually comes out.
Alan
poster:alan
thread:117186
URL: http://www.dr-bob.org/babble/20020821/msgs/117525.html